<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2444-6483</journal-id>
<journal-title><![CDATA[Endoscopia]]></journal-title>
<abbrev-journal-title><![CDATA[Endoscopia]]></abbrev-journal-title>
<issn>2444-6483</issn>
<publisher>
<publisher-name><![CDATA[Asociación Mexicana de Endoscopia Gastrointestinal A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2444-64832019000600057</article-id>
<article-id pub-id-type="doi">10.24875/end.m19000050</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Utilidad de las pruebas bioquímicas y ultrasonográficas para indicar CPRE en pacientes con ictericia sin necesidad de colangiorresonancia magnética]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Luis-Sánchez]]></surname>
<given-names><![CDATA[Diana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Camacho-Najera]]></surname>
<given-names><![CDATA[Miguel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Armienta-Sarabia]]></surname>
<given-names><![CDATA[Rolando]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández-Gómez]]></surname>
<given-names><![CDATA[María Elena]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto de Seguridad y Servicios Sociales de los Trabajadores Hospital Regional &#8220;General Ignacio Zaragoza&#8221; Servicio de Endoscopia Gastrointestinal]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2019</year>
</pub-date>
<volume>31</volume>
<fpage>57</fpage>
<lpage>61</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2444-64832019000600057&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2444-64832019000600057&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2444-64832019000600057&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción: En México no existe un estudio que especifique la sensibilidad de las pruebas bioquímicas y/o ultrasonograficas para diagnosticar ictericia obstructiva e indicar CPRE, lo cual cobra utilidad dado que no se cuenta de forma rutinaria con colangiorresonancia magnética en todas la unidades médicas.Buscamos establecer la sensibilidad de las pruebas bioquímicas y ultrasonograficas para indicar CPRE de forma directa en pacientes con ictérica, a manera de agilizar el proceso diagnóstico/terapéutico en el Hospital Regional Ignacio Zaragoza.  Objetivo: Comparar la utilidad de los Criterios ultrasonograficos y bioquímicos para indicar Colangiopancreatografía retrograda endoscópica sin necesidad de usar colangiorresonancia magnética.  Material y métodos: Se analizarán los métodos bioquímicos y ecográficos de forma estricta para establecer tres grupos de pacientes:1. Pacientes con alto riesgo de tener Proceso obstructivo de la vía biliar: pacientes con historia de colangitis aguda, ictericia y/o coledocolitiasis demostrada por ecografía, y con elevación de la FA, ALT y bilirrubinas. 2. Riesgo moderado: pacientes sin evidencia de historia de ictericia o colangitis, pero con alteraciones analíticas o bien dilatación de la VBP en la ecografía como signo indirecto, Bajo riesgo: parámetros dentro de la normalidad.  Resultados y conclusiones: Durante los Año y medio de seguimiento se recabaron datos de 357 pacientes con indicación de CPRE por diagnóstico de coledocolitiasis o alta sospecha proceso obstructivo de la vía biliar. De los cuales se descartaron 70 pacientes por no cumplir con todos los valores. Del total de pacientes 102 (35.54%) fueron hombres y 185(64.45%) fueron mujeres. La edad promedio Las pruebas de función hepática FA, TGP y BT fueron todos factores pronósticos para coledocolitiasis en análisis univariado con niveles de p&lt;0.01. No se incluyó en la historia la presentación clínica. No lograron valor estadístico la edad, TGO y GGTP.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction: In Mexico, there is no study that specifies the sensitivity of biochemical and/or ultrasonographic tests to diagnose obstructive jaundice and indicate ERCP, which is useful given that magnetic cholangioresonance is not routinely reported in all medical units. We seek to establish the sensitivity of biochemical and ultrasonographic tests to indicate ERCP directly in icteric patients, in order to speed up the diagnostic/therapeutic process in the Regional Hospital Ignacio Zaragoza.  Objective: To compare the usefulness of ultrasonographic and biochemical criteria to indicate endoscopic retrograde cholangiopancreatography without the need to use magnetic cholangioresonance.  Material and methods: The biochemical and ultrasound methods will be strictly analyzed to establish three groups of patients 1. Patients at high risk of having an obstructive process of the bile duct: patients with a history of acute cholangitis, jaundice and/or choledocholithiasis demonstrated by ultrasound, and with elevation of AF, ALT and bilirubins. 2. Moderate risk: patients without evidence of history of jaundice or cholangitis, but with analytical alterations or VBP dilatation in ultrasound as an indirect sign. Low risk: parameters within normality.  Results and conclusions: During the year and a half of follow-up, data were collected from 357 patients with indication for ERCP due to a diagnosis of choledocholithiasis or a high suspicion of biliary obstruction. Of which 70 patients were discarded for not meeting all the values. Of the total of patients 102 (35.54%) were men and 185 (64.45%) were women. The average age. The liver function tests FA, TGP and BT were all prognostic factors for choledocholithiasis in univariate analysis with p &lt;0.01 levels. The clinical presentation was not included in the story. Age, TGO and GGTP did not achieve statistical value.]]></p></abstract>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moises]]></surname>
<given-names><![CDATA[Ilan Nevah Rubina]]></given-names>
</name>
</person-group>
<source><![CDATA[Endoscopic retrograde cholangiopancreatography for suspected choledocholithiasis:Testing the current guidelines. 2013, de Digestive and Liver Disease Sitio]]></source>
<year>2012</year>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Isherwood]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Garcea]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[(2014), Serology and ultrasound for diagnosis of choledocholithiasis 2014, de Department of Hepatobiliary and Pancreatic Surgery, Leicester General Hospital, Gwendolen Road]]></article-title>
<source><![CDATA[Sitio web:Ann R Coll Surg Engl]]></source>
<year>2014</year>
<volume>96</volume>
<page-range>224-8</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[John]]></surname>
<given-names><![CDATA[T. Maple Tamir]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The role of endoscopy in the evaluation of suspected choledocholithiasis]]></article-title>
<source><![CDATA[2010, de American Societyfor Gastrointestinal Endoscopy]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miroslav]]></surname>
<given-names><![CDATA[Stojadinovic M.a]]></given-names>
</name>
<name>
<surname><![CDATA[Tomislav]]></surname>
<given-names><![CDATA[Pejovicb]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Regression tree for choledocholithiasis prediction]]></article-title>
<source><![CDATA[20 January 2015, de European Journal of Gastroenterology &amp;Hepatology]]></source>
<year>2015</year>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bilal]]></surname>
<given-names><![CDATA[O. Al-Jiffry,a]]></given-names>
</name>
</person-group>
<source><![CDATA[A scoring system for the prediction of choledocholithiasis:a prospective cohort study. 2016 JANUARY-FEBRUARY, de aDepartment of Surgery, Taif University, College of Medicine and Medical Sciences, Taif, Saudi Arabia]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Predrag]]></surname>
<given-names><![CDATA[Jovanovi&#263;a,*]]></given-names>
</name>
<name>
<surname><![CDATA[Nermin]]></surname>
<given-names><![CDATA[N. Salki&#263;]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Biochemical and ultrasound parameters may help predict the need for therapeutic endoscopic retrograde cholangiopancreatography (ERCP) in patients with a firm clinical and biochemical suspicion for choledocholithiasis]]></article-title>
<source><![CDATA[5 March 2011, de European Journal of Internal Medicine]]></source>
<year>2011</year>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<collab>Jingu Kang a Kyu-hyun Paik b</collab>
<article-title xml:lang=""><![CDATA[The Efficacy of Clinical Predictors for Patients with Intermediate Risk of Choledocholithiasis. September 17, 2016, de Department of Internal Medicine]]></article-title>
<source><![CDATA[Daerim Saint Mary's Hospital]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Riggle]]></surname>
<given-names><![CDATA[Andrew J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An analysis of omitting biliary tract imaging in 668 subjects admitted to an acute care surgery service with biochemical evidence of choledocholithiasis]]></article-title>
<source><![CDATA[The American Journal of Surgery]]></source>
<year>2015</year>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dharmendra Verma MD]]></surname>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[EUS vs MRCP for detection of choledocholithiasis]]></article-title>
<source><![CDATA[2016, de the American Society for Gastrointestinal Endoscopy]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Joana]]></surname>
<given-names><![CDATA[TOZATTI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[PREDICTOR FACTORS FOR CHOLEDOCHOLITHIASIS]]></article-title>
<source><![CDATA[13/11/2014, de Hospital Regional Dr. Homero de Miranda Gomes]]></source>
<year>2015</year>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Megan]]></surname>
<given-names><![CDATA[A. Adams1]]></given-names>
</name>
<name>
<surname><![CDATA[Amy]]></surname>
<given-names><![CDATA[E. Hosmer1]]></given-names>
</name>
</person-group>
<source><![CDATA[(2015), Predicting the likelihood of a persistent bile duct stone in patients with suspected choledocholithiasis:accuracy of existing guidelines and the impact of laboratory trends]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Ann Arbor, MI, USA ]]></publisher-loc>
<publisher-name><![CDATA[de Division of Gastroenterology, Department of Internal Medicine, University of Michigan Medical School]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Varayu]]></surname>
<given-names><![CDATA[Prachayakul1*]]></given-names>
</name>
</person-group>
<source><![CDATA[(2014), Diagnostic yield of endoscopic ultrasonography in patients with intermediate or high likelihood of choledocholithiasis:a retrospective study from one university-based endoscopy center]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Bangkok, Thailand ]]></publisher-loc>
<publisher-name><![CDATA[de 1Department of Internal Medicine, Siriraj GI Endoscopy Center, Siriraj Hospital, Division of Gastroenterology, Faculty of Medicine, Mahidol University]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
